Inhaled nitric oxide shows promise as treatment for COVID-19 respiratory failure

Inhaled nitric oxide gas widens blood vessels in the lungs and is used to treat severe cardio-pulmonary conditions in newborns and adults.

Related Keywords

United States ,Massachusetts ,Sweden ,American ,Edwarda Bittner ,Pankaj Arora ,Peggys Lai ,Ariell Mueller ,Somnath Bose ,Bijan Safaee Fakhr ,Jonathanz Li ,Fumito Ichinose ,Stefano Cenci ,Timothyt Houle ,Piotr Harbut ,Lily Ramsey ,Lorenzo Berra ,Magnus Hedenstierna ,Louiek Scott ,Stefano Gianni ,Ryanw Carroll ,Sabrina Paganoni ,Daniel Tornberg ,Oluwaseun Akeju ,Valentina Giammatteo ,Vibhu Parcha ,Marnixe Heersink School Of Medicine ,University Of Alabama ,Genetics Clinic Program ,Translational Research Program ,Massachusetts General Hospital ,American Journal ,Critical Care ,Respiratory Care ,Reginald Jenney Associate Professor ,Harvard Medical ,Cardiovascular Clinical ,Raffaele Di Fenza ,Namans Shetty ,Olof Wall ,Clinical Trial ,Covid 19 ,Nitric Oxide ,Pneumonia ,Espiratory ,Flood ,Blood Vessels ,Hospital ,Lungs ,Medical School ,Medicine ,Oxygen ,Pandemic ,Research ,Cars ,